文献速递腹部技术与安全MR

肾功能损害患者接受固定剂量钆塞酸增强MRI后肾源性系统性纤维化风险

Risk of nephrogenic systemic fibrosis in patients with impaired renal function undergoing fixed-dose gadoxetic acid-enhanced magnetic resonance imaging.
PubMed 文献 · Abdom Radiol (NY) · 2021-03-20

本回顾性研究纳入204例肾功能损害患者,共接受424次固定剂量钆塞酸(2.5 mmol)增强MRI,随访中位20个月,未检出肾源性系统性纤维化(NSF)。NSF风险95%置信区间上限为每患者2.2%、每次检查1.1%。作者认为目前尚不能确定钆塞酸在该人群中的NSF风险,需进一步研究。

要点

  • 肾功能损害患者接受固定剂量钆塞酸增强MRI后,随访未检出NSF。
  • NSF风险95%CI上限:每患者2.2%,每次检查1.1%。
  • 作者认为尚不能确定钆塞酸在该人群中的NSF风险。
英文原文(摘要)· 点击展开

PURPOSE: To assess the risk of nephrogenic systemic fibrosis (NSF) in patients with renal impairment undergoing gadoxetic acid-enhanced magnetic resonance imaging.

METHODS: This retrospective study included patients who had an estimated glomerular filtration rate (eGFR) below 60 mL/min per 1.73 m2 or had undergone dialysis around the time of gadoxetic acid exposure from January 2010 to November 2019. All patients received at least one intravenous injection of gadoxetic acid at a fixed dose of 2.5 mmol. The primary endpoint was the development of NSF after exposure to gadoxetic acid based on Girardi's clinicopathological scoring system.

RESULTS: A total of 204 patients with renal impairment received 424 injections of gadoxetic acid, of which 131 and 54 had an eGFR of 30-59 and < 30 mL/min per 1.73 m2, respectively, and 19 had undergone hemodialysis. Eighty-two patients received multiple injections, with 23 receiving five or more injections. The dose of each exposure ranged from 0.02 to 0.07 mmol/kg and the cumulative doses ranged from 0.02 to 0.45 mmol/kg. Thirty-three patients had concomitant Child-Pugh class B or C cirrhosis. No NSF was detected during follow-up (median 20 months; range 6 days to 111 months). The upper bound of the 95% confidence interval for NSF risk was 2.2% and 1.1% per patient and examination, respectively.

CONCLUSION: No NSF was detected in this study. However, it is premature to ascertain the risk of NSF using gadoxetic acid in patients with renal impairment and further studies are warranted.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Tseng TY, Tseng JH, Huang BS, et al. Risk of nephrogenic systemic fibrosis in patients with impaired renal function undergoing fixed-dose gadoxetic acid-enhanced magnetic resonance imaging. Abdom Radiol (NY). 2021. PMID: 33742216. doi:10.1007/s00261-021-03045-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。